FUSION PHARMACEUTICALS INC (FUSN)

CA36118A1003 - Common Stock

21.45  -0.04 (-0.19%)

After market: 21.44 -0.01 (-0.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.07M1.46M1.44M0.000.00
Operating Expenses
101.30M89.50M83.46M37.94M18.22M
Research and Development
70.10M58.90M56.36M17.19M10.63M
Selling, General, and Administrative Expenses
31.20M30.60M27.10M20.74M7.59M
Operating Income
-99.23M-88.03M-82.02M-37.94M-18.22M
Interest Income/Expense
4.06M-1.94M580.00K330.00K580.00K
Other Income/Expense
1.06M530.00K270.00K-38.11M1.71M
Income Before Taxes
-94.11M-89.45M-81.17M-75.72M-15.94M
Income Tax
787.00K-1.84M-120.00K2.61M250.00K
Net Income
-94.90M-87.61M-81.05M-79.72M-16.19M
EBITDA
-97.89M-87.12M-81.39M-37.46M-17.93M
 
Per Share Data
EPS Diluted Total Ops
-1.45-2.00-1.90-1.91-0.39
Non GAAP EPS
-1.47-2.00-1.90N/AN/A
 
Statistics
Profit Margin
-4588.83%-6000.68%-5628.47%N/AN/A
Operating Profit Margin
-4798.45%-6029.45%-5695.83%N/AN/A

All data in USD

Charts